June 14, 2024

1883-LB: ATR-258 Is a Precision Modulator of ß2-AR Signaling That Improves Glucose Homeostasis and Is Safe in Humans

Key Points

Key points are not available for this paper at this time.

Abstract

Introduction Atrogi AB. Stock/Shareholder; Atrogi AB. E. Waara: Employee; Atrogi. J.M.A. de Jong: Employee; Atrogi AB. B. Pelcman: Consultant; Atrogi AB. T. Bengtsson: Stock/Shareholder; Atrogi, Sigrid therapeutics.

1883-LB: ATR-258 Is a Precision Modulator of ß2-AR Signaling That Improves Glucose Homeostasis and Is Safe in Humans

Key Points

Abstract

Cite This Study